The Market Online graphic with ASX-branded charts and the text "HotCopper Highlights" centred in white.
branded charts and the text "HotCopper Highlights" centred in white.
The Market Onlinea
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Welcome to HotCopper Highlights, where we take a good look at the stocks that got investors talking in the week that was. To wrap up week 37, we’ll start with the three most discussed stocks. 

The Watchlist — short video interviews with ASX leaders. Watch now.

Resolution Minerals (ASX: RML) is leading the pack, with the company’s Nasdaq debut driving plenty of attention. Resolution began trading its American Depositary Shares on the Nasdaq this week, adding a second market for the explorer as it continues its Horse Heaven exploration campaign in Idaho. The company’s ASX shares have also been highly active, with drilling updates and the US listing keeping investors highly engaged.

Anson Resources (ASX: ASN) is also attracting plenty of discussion after flagging another capital raising, just weeks after its previous raise. The lithium developer has been working to advance its Green River Lithium Project in Utah, with recent announcements including a $193 million incentive from the Utah Inland Port Authority. 

And Invictus Energy (ASX: IVZ) remains a major talking point, with its massive media thread continuing to rack up posts as investors look ahead to the Musuma-1 exploration well in Zimbabwe, scheduled to spud in November. 

As for the most viewed stocks, BrainChip (ASX: BRN) is right at the top of the list. The neuromorphic AI company has been attracting renewed attention around its technology and latest corporate developments, with its second-quarter 2026 earnings call held on Thursday. 

Resolution Minerals also features among the most viewed, with the Nasdaq listing continuing to create feverish interest around the stock.

And Racura Oncology (ASX: RAC) rounds out the list, with investors following its clinical development pipeline, including the RC220 cancer treatment program. The company opened patient enrolment for its CPACS trial in Korea earlier this month, while its HARNESS-1 lung cancer trial is also progressing.

Join the discussion: See what HotCopper users are saying right now and be part of the conversations that move the markets.

More From The Market Online

Voltaic Strategic Resources identifies copper target with field work at El Dinero

Voltaic Strategic Resources has received positive initial results from first-stage field work at the El Dinero…

Invictus Energy awards key services contract to SLB for Musuma-1 well

Invictus Energy is on target to follow-up southern Africa's biggest recent discoveries with the drilling of…
HotCopper Daily Market Trends Graphic

Friday’s HotCopper trends: Buru Energy, Invictus Energy, BPM Minerals and other daily topics

With more than 600k average monthly users on the HotCopper forums, each and every discussion can…

PYC Therapeutics doses first patient in OLE study supporting kidney disease candidate

PYC Therapeutics has dosed the first patient in a Part D open-label extension (OLE) of an…